Bausch + Lomb will acquire Ista Pharmaceuticals for approximately $500 million, or $9.10 per share, according to a Bausch + Lomb news release.
125008
Bausch + Lomb to acquire Ista Pharmaceuticals
109022
United Drug buys Sharp Corporation for $99 million
34605
Eli Lilly acquires SGX Pharmaceuticals
17468
Pernix Therapeutics acquires antibiotic Cedax
43090
Boston Scientific to acquire BridgePoint Medical
168507
PharMerica signs asset purchase agreement to acquire Chem Rx Corporation
8553
Brightpoint to be acquired in $840 million deal
140988
GE Healthcare enters agreement to acquire assets of Orbotech Medical
34689
MultiPlan acquired by private equity firms
78206
Bausch & Lomb opens new pharmaceutical headquarters
49049
Zui acquired by Saban Brands
60006
ON semi completes acquisition
171449
Dachser acquires in the UK
51501
ZymoGenetics offering $79 million in common stock
32704
Burton Group acquired by Gartner
134649
Cubist Pharmaceuticals completes acquisition of Adolor Corporation
35490
Walgreen buys Drugstore.com for $409m